Steroids: The physiological and pharmacological effects of glucocorticoids;Szteroidok: A glükokortikoidok élettani és gyógyszertani hatásai

Orvosi Hetilap

Volumn 156, Issue 35, 2015, Pages 1415-1425

  Zelena, Dóra ^a   Makara, B Gábor ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Function; Glucocorticoids; Pathophysiology; Pharmacokinetics; Receptors

Indexed keywords

DRUG RECEPTOR; GLUCOCORTICOID; CATECHOLAMINE;

ARTICLE; BONE METABOLISM; CARDIOVASCULAR EFFECT; CENTRAL NERVOUS SYSTEM; DRUG METABOLISM; DRUG RECEPTOR BINDING; DRUG TRANSPORT; METABOLIC SYNDROME X; SECOND CERVICAL VERTEBRA; ADAPTATION; ANIMAL; BIOSYNTHESIS; BONE; CARDIOVASCULAR SYSTEM; CONNECTIVE TISSUE; DRUG EFFECTS; HISTORY; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNE SYSTEM; METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BONE AND BONES; CARDIOVASCULAR SYSTEM; CATECHOLAMINES; CENTRAL NERVOUS SYSTEM; CONNECTIVE TISSUE; GLUCOCORTICOIDS; HISTORY, 20TH CENTURY; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNE SYSTEM; METABOLIC SYNDROME X; PITUITARY-ADRENAL SYSTEM; STRESS, PHYSIOLOGICAL;

EID: 84946090382     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/650.2015.30248     Document Type: Article

References (46)

1. Ericson-Neilsen, W., Kaye, A. D.: Steroids: pharmacology, complications, and practice delivery issues. Ochsner J., 2014, 14(2), 203-207.
2. Selye, H.: A syndrome produced by diverse nocuous agents. 1936. J. Neuropsychiatry Clin. Neurosci., 1998, 10(2), 230a- 231a.
3. Szabo, S., Tache, Y., Somogyi, A.: The legacy of Hans Selye and the origins of stress research: A retrospective 75 years after his landmark brief "Letter" to the Editor of Nature. Stress, 2012, 15(5), 472-478.
4. http://rheumatology.oxfordjournals.org/cgi/content/full/41/5/582.
5. Fonyó, A., Ligeti, E.: Textbook of medicinal physiology. [Az orvosi élettan tankönyve.] Medicina Könyvkiadó, Budapest, 2008. [Hungarian].
6. Ota, A., Mase, J., Howteerakul, N., et al.: The effort-reward imbalance work-stress model and daytime salivary cortisol and dehydroepiandrostero ne (DHEA) among Japanese women. Sci. Rep., 2014, 4, 6402.
7. Taves, M. D., Gomez-Sanchez, C. E., Soma, K. K.: Extra-adrenal glucocorticoids and mineralocorticoids: evidence for local synthesis, regulation, and function. Am. J. Physiol. Endocrinol. Metab., 2011, 301(1), E11-E24.
8. Wosu, A. C., Valdimarsdóttir, U., Shields, A. E., et al.: Correlates of cortisol in human hair: implications for epidemiologic studies on health effects of chronic stress. Ann. Epidemiol., 2013, 23(12), 797-811.e2.
9. Spiga, F., Waite, E. J., Liu, Y., et al.: ACTH-dependent ultradian rhythm of corticosterone secretion. Endocrinology, 2011, 152(4), 1448-1457.
10. Walker, J. J., Spiga, F., Waite, E., et al.: The origin of glucocorticoid hormone oscillations. PLoS Biol., 2012, 10(6), e1001341.
11. Schülke, B., Tegeler, G.: Relationship between the quality o f dietary prot eins and the functional status of the adrenal cortex. Variations in the content of transcortion, free corticosterone and total corticosterone in the blood plasma of rats fed with proteins of various quality. Arch. Tierernahr., 1975, 25(6), 453-462.
12. Moisan, M. P., Minni, A. M., Dominguez, G., et al.: Role of corticosteroid binding globulin in the fast actions of glucocorticoids on the brain. Steroids, 2014, 81, 109-115.
13. Katayama, S., Yamaji, T.: A binding-protein for aldosterone in human plasma. J. Steroid Biochem., 1982, 16(2), 185-192.
14. Nicolaides, N. C., Galata, Z., Kino, T., et al.: The human glucocorticoid receptor: molecular basis of biologic function. Steroids, 2010, 75(1), 1-12.
15. De Kloet, E. R.: From receptor balance to rational glucocorticoid therapy. Endocrinology, 2014, 155(8), 2754-2769.
16. Haller, J., Mikics, E., Makara, G. B.: The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. Acritical evaluation of fi ndings. Front. Neuroendocrinol., 2008, 29(2), 273-291.
17. Liu, X., Wang, C. A., Chen, Y. Z.: Nongenomic effect of glucocorticoid on the release of arginine vasopressin from hypothalamic slices inrats. Neuroendocrinology, 1995, 62(6), 628-633.
18. Dooley, R., Harvey, B. J., Thomas, W.: Non-g enomic actions of aldosterone: from receptors and signals to membrane targets. Mol. Cell. Endocrinol., 2012, 350(2), 223- 234.
19. Gauer, S., Segitz, V., Goppelt-Struebe, M.: Aldosterone induces CTGF in mesangial cells by activation of the glucocorticoid receptor. Nephrol. Dial. Transplant., 2007, 22(11), 3154-3159.
20. Makara, G. B., Harbuz, M. S., Coventry, T. L., et al.: The effect of hypothalamic lesions on hypothalamo-pituitary-adrenal axis activity and infl ammation in adjuvant-induced arthritis. Stress, 2001, 4(1), 25-37.
21. Zelena, D., Filaretova, L., Mergl, Z., et al.: Hypothalamic paraventricular nucleus, but not vasopressin, participates in chronic hyperactivity of the HPA axis in diabetic rats. Am . J. Physiol. Endocrinol. Metab., 2006, 290(2), E243-E250.
22. Makara, G. B., Varga, J., Barna, I., et al.: The vasopressin-defi - cient Brattleboro rat: lessons for the hypothalamo-pituitary-adrenal axis regulation. Cell. Mol. Neurobiol., 2012, 32(5), 759- 766.
23. Bornstein, S. R., Engeland, W. C., Ehrhart-Bornstein, M., et al.: Dissociation of ACTH and glucocorticoids. Trends Endocrinol. Metab., 2008, 19(5), 175-180.
24. Varga, J., Ferenczi, S., Kovács, K. J., et al.: Comparison of stressinduced changes in adults and pups: is aldosterone the main adrenocortical stress hormone during the perinatal period in rats? PLoS ONE, 2013, 8(9), e72313.
25. Elifanov, A. V., Polenov, A. L., Belen'kii, M. A., et al.: Morphofunctional research on the interrenal gland of the frog Rana temporaria following arginine vasotocin administration. Zh. Evol. Biokhim . Fiziol., 1988, 24(5), 740-744.
26. Sapolsky, R. M., Romero, L. M., Munck, A. U.: How do glucocorticoids influences stress responses? Integrating permissive, supp ressive, stimulatory, and preparative actions. Endocr. Rev., 2000, 21(1), 55-89.
27. Sapolsky, R. M.: McEwen-induced modulation of endocrine history: A partial review. Stress, 1997, 2(1), 1-12.
28. Rose, A. J., Herzig, S.: Metabolic control through glucocorticoid hormones: An update. Mol. Cell. Endocrinol., 2013, 380(1-2), 65-78.
29. Uchoa, E. T., Aguilera, G., Herman, J. P., et al.: Novel aspects of glucocorticoid actions. J. Neuroendocrinol., 2014, 26(9), 557- 572 .
30. Sorrells, S. F., Caso, J. R., Munhoz, C. D., et al.: The stressed CNS: when glucocorticoids aggravate infl ammation. Neuron, 2009, 64(1), 33-39.
31. Johnson, J. D., O'Connor, K. A., Deak, T., et al.: Prior stressor exposure sensitizes LPS-induced cytokine production. Brain Behav. Immun., 2002, 16(4), 461-476.
32. Li, X. Q., Zhu, P., Myatt, L., et al.: Roles of glucocorticoids in human parturition: A controversial fact? Placenta, 2014, 35(5), 291-296.
33. Gobinath, A. R., Mahmoud, R., Galea, L. A.: influences of sex and stress exposure across the lifespan on endophenotypes of depression: focuson behavior, glucocorticoids, and hippocampus. Front. Neurosci., 2014, 8, 420.
34. Engel, G. L.: The biopsychosocial model and the education of health professionals. Ann. N. Y. Acad. Sci., 1978, 310, 169-181.
35. Daskalakis, N. P., Bagot, R. C., Parker, K. J., et al.: The three-hit concept of vulnerability and resilie nce: Toward understanding adaptation to early-life adversity outcome. Psychoneuroendocrinology, 2013, 38(9), 1858-1873.
36. Wingenfeld, K., Wolf, O. T.: Stress, memory, and the hippocampus. Front. Neurol. Neurosci., 2014, 34, 109-120.
37. Haller, J.: The glucocorticoid/aggression relationship in animals and humans: An analysis sensitive to behavioral characteristics, glucocorticoid secretion patterns, and neural mechanisms. Curr. Top. Behav. Neurosci., 2014, 17, 73-109.
38. Delahanty, D. L., R aimonde, A. J., Spoonster, E.: Initial posttraumatic urinary cortisol levels predict subsequent PTSD symptoms in motor vehicle accident victims. Biol. Psychiatry, 2000, 48(9), 940-947.
39. Vinson, G. P.: The adrenal cortex and life . Mol. Cell. Endocrinol., 2009, 300(1-2), 2-6.
40. Zelena, D., Makara, G. B.: The role of adrenocorticotropin beyond the glucocorticoid horizon. In: Berhardt, L. V. (ed.): Advances in medicine and biology. Vol. 43. Nova Science Publisher, 2012.
41. Tierney, L. M., McPhee, S. J., Papadakis, M. A.: Current medical diagnosis and treatment 2007. [Korszeru orv osi diagnosztika és terápia 2007.] Melania Kiadó, Budapest, 2008. 1996. [Hungarian].
42. Triadafi lopoulos, G.: Glucocorticoid therapy for gastrointestinal diseases. Expert Opin. Drug Saf., 2014, 13(5), 563-572.
43. Filaretova, L. P.: Activation of the hypothalamo-hypophysealadrenocortical system as an important gastroprotective component of the stress reaction. Neurosci. Behav. Physiol., 2007, 37(4), 355-362.
44. Fredman, G., Kamaly, N., Spolitu, S., et al.: Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice. Sci. Transl. Med., 2015, 7(275), 275ra20.
45. Maubec, E., Laouénan, C., Deschamps, L., et al.: Topica l mineralocorticoid receptor blockade limits glucocorticoid-induced epidermal atrophy in human skin. J. Invest. Dermatol., 2015, 135(7), 1781-1789.
46. Robinzon, B., Cutolo, M.: Should dehydroepiandrosterone replacement therapy be provided with glucocorticoids? Rheumatology (Oxford), 1999, 38(6), 488-495.